Showing results (11-20 of 59) with videos related to

Sort By:
Pageof 6
Genetics in Medicine : Official Journal of the American College of Medical Genetics|January 18, 2005
An evaluation of BRCA1 and BRCA2 founder mutations penetrance estimates for breast cancer among Ashkenazi Jewish womenMonica R McClain, Katherine L Nathanson, Glenn E Palomaki, et al.
Prenatal Diagnosis|March 11, 2003
Maternal serum-integrated screening for trisomy 18 using both first- and second-trimester markersGlenn E Palomaki, Louis M Neveux, George J Knight, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|March 8, 2002
Updated assessment of cystic fibrosis mutation frequencies in non-Hispanic CaucasiansGlenn E Palomaki, James E Haddow, Linda A Bradley, et al.
Obstetric Medicine|March 1, 2013
Maternal Body Mass Index during Pregnancy and Offspring Neurocognitive DevelopmentWendy Y Craig, Glenn E Palomaki, Louis M Neveux, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|January 18, 2005
Adjusting the estimated proportion of breast cancer cases associated with BRCA1 and BRCA2 mutations: public health implicationsMonica R McClain, Glenn E Palomaki, Katherine L Nathanson, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|January 25, 2003
Analytic validity of cystic fibrosis testing: a preliminary estimateGlenn E Palomaki, Linda A Bradley, C Sue Richards, et al.
The Journal of Clinical Endocrinology and Metabolism|January 4, 2007
Urine iodine measurements, creatinine adjustment, and thyroid deficiency in an adult United States populationJames E Haddow, Monica R McClain, Glenn E Palomaki, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|August 2, 2007
Estimating first-trimester combined screening performance for Down syndrome in dried blood spots versus fresh seraGlenn E Palomaki, Louis M Neveux, George J Knight, et al.
Clinical Chemistry|August 21, 2004
Maternal serum invasive trophoblast antigen (hyperglycosylated hCG) as a screening marker for Down syndrome during the second trimesterGlenn E Palomaki, Louis M Neveux, George J Knight, et al.
Clinical Chemistry|June 18, 2005
Maternal serum invasive trophoblast antigen and first-trimester Down syndrome screeningGlenn E Palomaki, George J Knight, Louis M Neveux, et al.
Pageof 6